Literature DB >> 25841659

Paclitaxel-loaded expansile nanoparticles enhance chemotherapeutic drug delivery in mesothelioma 3-dimensional multicellular spheroids.

Hongyi Lei1, Sophie C Hofferberth2, Rong Liu2, Aaron Colby3, Kristie M Tevis3, Paul Catalano2, Mark W Grinstaff3, Yolonda L Colson4.   

Abstract

OBJECTIVES: Intraperitoneal administration of paclitaxel-loaded expansile nanoparticles (Pax-eNPs) significantly improves survival in an in vivo model of malignant mesothelioma compared with conventional drug delivery with the clinically utilized Cremophor EL/ethanol (C/E) excipient. However, in vitro monolayer cell culture experiments do not replicate this superior efficacy, suggesting Pax-eNPs utilize a unique mechanism of drug delivery. Using a mesothelioma spheroid model, we characterized the mechanisms of enhanced tumor cytotoxicity leveraged by Pax-eNPs.
METHODS: Human malignant mesothelioma (MSTO-211H) spheroids were co-incubated for 24 hours with Oregon Green-conjugated paclitaxel dissolved in C/E or loaded into eNPs. Oregon Green-paclitaxel uptake was measured as Oregon Green intensity via confocal microscopy and kinetics of tumor cytotoxicity were assessed via propidium iodide staining. Pharmacologic endocytotic inhibitors were used to elucidate mechanisms of eNP uptake into spheroids.
RESULTS: Increased drug penetration and a 38-fold higher intraspheroidal drug concentration were observed 24 hours after MSTO-211H spheroids were treated with Oregon Green-conjugated paclitaxel loaded into eNPs compared with Oregon Green-conjugated paclitaxel dissolved in C/E (P < .01). Macropinocytosis was the dominant endocytotic pathway of eNP uptake. Spheroids were more susceptible to paclitaxel when delivered via eNP, exhibiting more than twice the propidium iodine intensity compared with an equivalent paclitaxel-C/E dose.
CONCLUSIONS: Compared with monolayer cell culture, the in vitro 3-D tumor spheroid model better reflects the superior in vivo efficacy of Pax-eNPs. Persistent tumor penetration and prolonged intratumoral release are unique mechanisms of Pax-eNP cytotoxicity. 3-D spheroid models are valuable tools for investigating cytotoxic mechanisms and nanoparticle-tumor interactions, particularly given the costs and limitations of in vivo animal studies.
Copyright © 2015 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  mesothelioma; nanoparticle; paclitaxel; spheroids

Mesh:

Substances:

Year:  2015        PMID: 25841659     DOI: 10.1016/j.jtcvs.2015.02.020

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  11 in total

1.  Tumor-mesoporous silica nanoparticle interactions following intraperitoneal delivery for targeting peritoneal metastasis.

Authors:  Derek Hargrove; Brian Liang; Raana Kashfi-Sadabad; Gaurav N Joshi; Laura Gonzalez-Fajardo; Sterling Glass; Michael Jay; Andrew Salner; Xiuling Lu
Journal:  J Control Release       Date:  2020-11-07       Impact factor: 9.776

Review 2.  Nanoparticle drug-delivery systems for peritoneal cancers: a case study of the design, characterization and development of the expansile nanoparticle.

Authors:  Aaron H Colby; Nicholas H Oberlies; Cedric J Pearce; Victoria L M Herrera; Yolonda L Colson; Mark W Grinstaff
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-02-09

3.  Nanoparticle tumor localization, disruption of autophagosomal trafficking, and prolonged drug delivery improve survival in peritoneal mesothelioma.

Authors:  Rong Liu; Aaron H Colby; Denis Gilmore; Morgan Schulz; Jialiu Zeng; Robert F Padera; Orian Shirihai; Mark W Grinstaff; Yolonda L Colson
Journal:  Biomaterials       Date:  2016-06-23       Impact factor: 12.479

4.  Nanoparticle-based targeted gene therapy for lung cancer.

Authors:  Hung-Yen Lee; Kamal A Mohammed; Najmunnisa Nasreen
Journal:  Am J Cancer Res       Date:  2016-05-01       Impact factor: 6.166

5.  Paclitaxel-loaded expansile nanoparticles improve survival following cytoreductive surgery in pleural mesothelioma xenografts.

Authors:  Ngoc-Quynh Chu; Rong Liu; Aaron Colby; Claire de Forcrand; Robert F Padera; Mark W Grinstaff; Yolonda L Colson
Journal:  J Thorac Cardiovasc Surg       Date:  2020-01-13       Impact factor: 5.209

6.  Embedded Spheroids as Models of the Cancer Microenvironment.

Authors:  Kristie M Tevis; Yolonda L Colson; Mark W Grinstaff
Journal:  Adv Biosyst       Date:  2017-08-18

7.  Evaluation of expansile nanoparticle tumor localization and efficacy in a cancer stem cell-derived model of pancreatic peritoneal carcinomatosis.

Authors:  Victoria Lm Herrera; Aaron H Colby; Glaiza Al Tan; Ann M Moran; Michael J O'Brien; Yolonda L Colson; Nelson Ruiz-Opazo; Mark W Grinstaff
Journal:  Nanomedicine (Lond)       Date:  2016-04-14       Impact factor: 5.307

Review 8.  Pre-clinical Models for Malignant Mesothelioma Research: From Chemical-Induced to Patient-Derived Cancer Xenografts.

Authors:  Noushin Nabavi; Jingchao Wei; Dong Lin; Colin C Collins; Peter W Gout; Yuzhuo Wang
Journal:  Front Genet       Date:  2018-07-04       Impact factor: 4.599

9.  Imaging techniques in nanomedical research.

Authors:  Laura Calderan; Manuela Malatesta
Journal:  Eur J Histochem       Date:  2020-07-01       Impact factor: 3.188

10.  Cellular uptake mechanism and comparative evaluation of antineoplastic effects of paclitaxel-cholesterol lipid emulsion on triple-negative and non-triple-negative breast cancer cell lines.

Authors:  Jun Ye; Xuejun Xia; Wujun Dong; Huazhen Hao; Luhua Meng; Yanfang Yang; Renyun Wang; Yuanfeng Lyu; Yuling Liu
Journal:  Int J Nanomedicine       Date:  2016-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.